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In Brief
The brain senses lipids, such as fatty
acids, and modifies energy metabolism
accordingly. However, it is unclear
whether other lipid species may be
involved. Contreras et al. now demon-
strate that ceramides regulate energy bal-
ance through the induction of hypotha-
lamic lipotoxicity and modulation of
endoplasmic reticulum functionality.
This leads to changes in sympathetic
tone and brown adipose tissue (BAT)-
induced thermogenesis, impacting body
weight.
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Hypothalamic endoplasmic reticulum (ER) stress is
a key mechanism leading to obesity. Here, we
demonstrate that ceramides induce lipotoxicity and
hypothalamic ER stress, leading to sympathetic
inhibition, reduced brown adipose tissue (BAT)
thermogenesis, and weight gain. Genetic overex-
pression of the chaperone GRP78/BiP (glucose-
regulated protein 78 kDa/binding immunoglobulin
protein) in the ventromedial nucleus of the hypothal-
amus (VMH) abolishes ceramide action by reducing
hypothalamic ER stress and increasing BAT thermo-
genesis, which leads to weight loss and improved
glucose homeostasis. The pathophysiological rele-
vance of this mechanism is demonstrated in obese
Zucker rats, which show increased hypothalamic
ceramide levels and ER stress. Overexpression of
GRP78 in the VMH of these animals reduced body
weight by increasing BAT thermogenesis as well as
decreasing leptin and insulin resistance and hepatic
steatosis. Overall, these data identify a triangulated
signaling network involving central ceramides, hypo-
thalamic lipotoxicity/ER stress, and BAT thermogen-
esis as a pathophysiological mechanism of obesity.
INTRODUCTION
Obesity and its related metabolic disorders are increasing at a
rate that is considered of epidemic proportions in Western and366 Cell Reports 9, 366–377, October 9, 2014 ª2014 The Authorsdeveloping countries. The increasing prevalence of obesity is
likely due to a combination of genetic predisposition as well as
evolutionary, social, and environmental factors (Gregor and Ho-
tamisligil, 2011; Ramachandrappa and Farooqi, 2011; Speak-
man and O’Rahilly, 2012). Data gleaned over the last few years
have uncovered the interaction between peripheral signals and
brain targets provided by different neuropeptides and neuro-
transmitters (Lam et al., 2005; Luquet and Magnan, 2009; Yeo
and Heisler, 2012). However, despite initial hope, this knowledge
failed to provide a much-needed antiobesity drug (Finan et al.,
2012; Dietrich and Horvath, 2012; Malik et al., 2013). It is gener-
ally recognized that to progress in this area it is crucial to
discover the basic molecular mechanisms regulating energy ho-
meostasis. Taking into account that almost all signaling proteins
used by cells to communicate with its environment are assem-
bled in the endoplasmic reticulum (ER) (Schro¨der and Kaufman,
2005; Ron and Walter, 2007; Gregor and Hotamisligil, 2011; Fu
et al., 2012), studies addressing the molecular mechanisms
involved in ER stress functions have started to reveal the molec-
ular mechanisms involved in complex diseases.
The ER is a sophisticated luminal network in which pro-
tein synthesis, maturation, folding, and transport take place
(Schro¨der and Kaufman, 2005; Marciniak and Ron, 2006; Ron
and Walter, 2007; Gregor and Hotamisligil, 2011; Fu et al.,
2012). The term ER stress refers to the alterations of the pro-
tein-folding functionality of the ER, which activates a complex
signaling network termed the unfolded protein response (UPR),
leading to coordinated transcriptional events promoting attenu-
ation of protein synthesis, upregulation of ER-folding machinery
(a type of proteins called chaperones), and degradation of
irreversibly misfolded proteins (Schro¨der and Kaufman, 2005;
Marciniak and Ron, 2006; Ron and Walter, 2007; Martı´nez de
Morentin and Lo´pez, 2010; Fu et al., 2012). Previous studies have
demonstrated that ER stress and activation of UPR pathways
play a major role promoting obesity-induced insulin resistance
in peripheral tissues. For example, inflammation, free lipid accu-
mulation, and hyperglycemia in pancreatic b cells and liver elicit
activation of the UPR, leading to decreased insulin expression
and inhibition of insulin signaling (Ozcan et al., 2004, 2006; Lip-
son et al., 2006; Kammoun et al., 2009; Fu et al., 2012). Current
evidence also indicates that obesity and overnutrition-induced
inflammation causes ER stress in the hypothalamus, inducing in-
sulin and leptin resistance and, ultimately, weight gain (Zhang
et al., 2008; Hosoi et al., 2008; Ozcan et al., 2009; Won et al.,
2009; Ropelle et al., 2010; Schneeberger et al., 2013). Notably,
these studies also demonstrate that pharmacological interven-
tions that improve protein folding (i.e., chemical chaperones)
recover leptin and insulin signaling, normalizing body weight
(Zhang et al., 2008; Hosoi et al., 2008; Ozcan et al., 2009; Won
et al., 2009; Schneeberger et al., 2013).
A current idea gaining credibility is that adipose stores in
some obese individuals become saturated and lipotoxic fat me-
tabolites spill over into tissues not suited for lipid storage (Virtue
and Vidal-Puig, 2010; Martı´nez de Morentin et al., 2010). Thus,
accumulation of reactive lipid species, such as diacylglycerol,
free fatty acids, free cholesterol, and ceramides, is a patho-
genic mechanism of insulin resistance, type 2 diabetes, and
liver and cardiovascular disease. In peripheral tissues, such
as b cells, skeletal muscle, liver, and heart, this process, known
as lipotoxicity, occurs through inflammation and ER stress (Un-
ger, 2002; Virtue and Vidal-Puig, 2008; Symons and Abel,
2013). However, despite this evidence, whether (1) lipotoxocity
may happen in the hypothalamus and, more specifically,
whether (2) ceramide-induced lipotoxicity may induce hypotha-
lamic ER stress or (3) this mechanism is of relevance for obesity
is currently unknown. Therefore, the aims of this study were
first to determine whether central ceramides elicit ER stress
in the hypothalamus, and second to investigate whether that
action accounts for the changes in energy balance associated
with obesity.
RESULTS
Central Ceramide Treatment Induced Hypothalamic ER
Stress and Body Weight Gain through Sympathetic
Inhibition of BAT
Central treatment of C6 ceramide, a cell-penetrating ceramide
that is partially converted to long-chain ceramides inside the
cell (Mitoma et al., 1998; Gao et al., 2011; Ramı´rez et al.,
2013), increased the concentration of C16 ceramide in the
mediobasal hypothalamus (MBH), confirming the efficiency of
the treatment (Figure 1A). This effect was associated with
increased ER stress, as demonstrated by the increased protein
concentration of the UPR, such as GRP78/BiP (glucose-regu-
lated protein 78 kDa/binding immunoglobulin protein), pIRE1
(phosphorylated inositol requiring enzyme 1), pPERK (phos-
phorylated PKR-like ER kinase), peIF2a (phosphorylated eu-
karyotic initiation factor 2a), ATF6a (activating transcription
factor 6 alpha), and CHOP (C/EBP homologous protein)
(Schro¨der and Kaufman, 2005; Marciniak and Ron, 2006; Ronand Walter, 2007; Martı´nez de Morentin and Lo´pez, 2010; Fu
et al., 2012) in the MBH (Figure 1B). Of note, central administra-
tion of ceramide induced a marked feeding-independent
weight gain (Figure 1C), which was associated with decreased
mRNA levels of thermogenic markers in BAT, such as uncou-
pling proteins 1 and 3 (UCP1 and UCP3), peroxisome-prolifera-
tor-activated receptor-gamma coactivator 1 alpha (PGC1a, but
not PGC1b), and fatty acid-binding protein 3 (FABP3) (Fig-
ure 1D). This was confirmed at the protein level as indicated
by the reduced UCP1 protein concentration in BAT (Figure 1E).
In keeping with the decreased expression of thermogenic
markers, central ceramide-treated rats displayed lower body
temperature (Figure 1F). Moreover, central administration of
ceramide reduced BAT sympathetic nerve traffic recorded
directly by microneurography (Figures 1G–1H).
GRP78 in the Ventromedial Nucleus of the
Hypothalamus Reversed the Central Ceramide Effect on
Body Weight and BAT Thermogenesis
To assess the role of ER stress on ceramide-induced actions on
energy balance, we targeted GRP78, an ER chaperone that fa-
cilitates the proper protein folding acting upstream of the UPR
(Schro¨der and Kaufman, 2005; Marciniak and Ron, 2006; Ron
and Walter, 2007; Martı´nez de Morentin and Lo´pez, 2010; Fu
et al., 2012; Cnop et al., 2012). Thus, an adenovirus encoding
GRP78 wild-type (GRP78 WT) together with GFP or control
adenovirus expressing GFP alone was injected first into the
ventromedial nucleus of the hypothalamus (VMH), a key site
modulating BAT (Lo´pez et al., 2010; Martı´nez de Morentin
et al., 2012, 2014; Whittle et al., 2012; Beiroa et al., 2014). Infec-
tion efficiency in the VMH was assessed by expression of GFP
(Figure 2A) and an increased concentration of GRP78 in the
VMH (Figure 2B). The specificity of the VMH dissections was
92.08% (p < 0.001) when using pro-opiomelanocortin (POMC)
as a marker of ‘‘contamination’’ from the neighboring arcuate
nucleus of the hypothalamus (ARC). GRP78 adenovirus elicited
a marked decrease in four out the five proteins of the UPR
tested in the VMH (Figure 2B), without changes in ceramide
levels (Figure 2C), indicating that GRP78 was acting down-
stream of ceramides. Of note, central ceramide treatment
increased the expression of inflammatory markers in the hypo-
thalamus such as interleukin 6 (IL6, but not IL1b), phospho-
IKKa/b (pIKKa/b), and tumor necrosis factor alpha (TNFa),
which is indicative of lipotoxicity (Figure S1A). Remarkably,
these effects of ceramide were not affected by GRP78 adeno-
virus (Figure S1A), confirming previous evidence that inflamma-
tion is upstream to ER stress in the hypothalamus (Zhang et al.,
2008). Moreover, we found that administration of GRP78 adeno-
virus into the VMH reversed ceramide-induced weight gain
without any change in food intake (Figure 2D). GRP78 WT
adenovirus did not affect body weight or feeding in vehicle-
treated rats (Figures S1B and S1C). Central ceramide promoted
an increase in the weight of gonadal and inguinal white adi-
pose tissue pads (gWAT and iWAT, respectively), an effect
that was reversed by GRP78 adenovirus into the VMH (Fig-
ure 2E). In association with the increased adiposity, ceramide-
treated rats showed a tendency for higher circulating leptin
and triacylglyceride (TAG) levels that was partially reversed byCell Reports 9, 366–377, October 9, 2014 ª2014 The Authors 367
Figure 1. Effect of Central Administration of Ceramide on Energy Balance
Ceramide levels in the mediobasal hypothalamus (MBH) (A), representative western blot autoradiographic images (B, left; spliced bands loaded in the same gel)
and hypothalamic protein levels of UPR (B, right), body weight change (C, left) and daily food intake (C, right), mRNA expression in the BAT (D), representative
western blot autoradiographic images (E, left; spliced bands loaded in the same gel) and protein levels of BAT UCP1 (E, right), rectal temperature (F), BAT
sympathetic nervous activity (SNA) tracings (G), and change in BAT SNA of rats centrally treated with vehicle or ceramide 6 (H). Error bars represent SEM; n = 5–7
(SNA recordings) or n = 7–26 animals per experimental group. *p < 0.05, **p < 0.01, and ***p < 0.001 versus vehicle, #p < 0.05 ceramide 0.2 mg ICV versus
ceramide 0.1 mg ICV.GRP78 WT adenovirus (Table S1). The central ceramide-medi-
ated decrease in UCP1 protein levels in the BAT (Figure 2F),
BAT temperature (Figure 2G), and body temperature (Fig-
ure 2H) were also blunted by administration of GRP78 adeno-
virus in the VMH. Overall, these changes indicated that the
central ceramide-induced ER stress effectively modulated
BAT thermogenesis.
Next, GRP78 WT adenoviruses were injected within the ARC
(Figure S1D), where they promoted an increase of the concentra-
tion of GRP78, which was concomitant to decreased levels of ER
stress markers (Figure S1E). The specificity of the ARC dissec-
tions was 83.48% (p < 0.001), when using steroidogenic fac-
tor-1 (SF1) as a marker of contamination from the adjacent
VMH. When given into the ARC, GRP78 WT adenovirus did not
affect body weight (Figure S1F), feeding (Figure S1G), or BAT
UCP1 protein content (Figure S1H).368 Cell Reports 9, 366–377, October 9, 2014 ª2014 The AuthorsGRP78 in the VMH Reversed the Central Ceramide
Effect on Insulin Resistance
Given the effects of central ceramide administration on body
weight and BAT thermogenesis, we next evaluated its impact
on glucose homeostasis and insulin action. Our data showed
that central ceramide did not impact glucose tolerance (Fig-
ure 3A) but impaired insulin sensitivity, which was reversed by
GRP78 adenovirus in the VMH (Figures 3B and 3C).
Inactivation of GRP78 in the VMH Induced ER Stress and
Weight Gain and Decreased UCP1 in BAT
Having shown that GRP78 overexpression in the VMH inhibited
central ceramide’s anabolic actions, we next investigated
whether GRP78 inactivation in the same hypothalamic nucleus
would have the opposite effect on body weight and BAT
markers. For this, we treated rats with an adenovirus harboring
Figure 2. Effect of GRP78 Overexpression in the VMH on Central Ceramide Actions and Energy Balance
(A–C) Representative immunofluorescence (A, left: 43, scale bar, 300 mm; A, right: 203, scale bar 100 mm) with anti-GFP showing GFP expression in the VMH,
representative western blot autoradiographic images (B, left; spliced bands loaded in the same gel) and hypothalamic protein levels of UPR (B, right; see Fig-
ure S1A for analysis of inflammatory markers in the hypothalamus), and ceramide levels (C) in the mediobasal hypothalamus of rats treated with GFP or GRP78
WT adenoviruses into the VMH.
(D–H) Body weight change (D, left) and daily food intake (D, right); weight of iBAT, gWAT, and iWAT pads (E); representative western blot autoradiographic images
(F, left; spliced bands loaded in the same gel) and protein levels of BAT UCP1 (F, right); representative infrared thermal images (G, left) and temperature of the BAT
area (G, right); and rectal temperature (H) of rats centrally treated with vehicle or ceramide and stereotaxically treated with GFP or GRP78 WT adenoviruses into
the VMH. In order to simplify (D)–(H), the vehicle Ad GRP78 WT group has been omitted; in any case, it is important to note that no differences were found in that
group when compared to vehicle Ad GFP (see Figures S1B and S1C).
Error bars represent SEM; n = 6 (fat pads and temperature) or 7–47 animals per experimental group. 3V, third ventricle; ME, median eminence. *p < 0.05, ** p <
0.01, and ***p < 0.001 versus Ad GFP or vehicle Ad GFP; #p < 0.05, ## p < 0.01, and ###p < 0.001 ceramide Ad GFP versus ceramide Ad GRP78WT. See Figures
S1D–S1H for analysis of GRP78 WT adenoviruses in the arcuate nucleus of the hypothalamus.a dominant-negative isoform of GRP78 (GRP78 DN) (Shen et al.,
2002) in the VMH or the ARC. Infection efficiency was assessed
by expression of GFP (similarly to Figures 2A and S1D for GRP78
WT) and increased concentration of GRP78 in the VMH or ARC,
since GRP78 DN isoform was most likely recognized by GRP78
antibody (Figures 4A and S2A). Our data demonstrated that ste-
reotaxic delivery of GRP78 DN induced a significant UPR activa-
tion in the VMH (Figure 4A), which accounts for increased ER
stress, feeding-independent weight gain (Figures 4B and 4C),
and decreased UCP1 concentration in BAT (Figure 4D). On the
other hand, despite ER stress induction in the ARC (Figure S2A),GRP78 DN adenovirus did not impact body weight (Figure S2B),
food intake (Figure S2C), or UCP1 protein levels in BAT
(Figure S2D).
GRP78 in the VMH Reversed Ceramide-Induced ER
Stress in Obese Zucker Rats
To elucidate the contribution of ceramide-induced ER stress in
the context of obesity, we used obese Zucker rats (OZR). Our
data showed increased concentration of ceramide C16 and
C18 in the MBH of OZR when compared to lean Zucker rats
(LZR) (Figure 5A). In addition, UPR response was increased inCell Reports 9, 366–377, October 9, 2014 ª2014 The Authors 369
Figure 3. Effect of GRP78 Overexpression in
the VMH on Central Ceramide Actions on
Glucose Homeostasis and Insulin Sensitivity
Glucose tolerance test (GTT) (A), insulin tolerance
test (ITT) (B), and area under the curve (AUC) (C)
from ITT of rats centrally treated with vehicle or
ceramide and stereotaxically treated with GFP or
GRP78 WT adenoviruses into the VMH. Error bars
represent SEM; n = 7–9 animals per experimental
group. *p < 0.05 versus vehicle Ad GFP; # p < 0.05
ceramide Ad GFP versus ceramide Ad GRP78 WT.the VMH of OZR (Figure 5B), indicating ER stress. Next, we eval-
uated the effect of GRP78 overexpression in the VMHof LZR and
OZR. Our results indicate that stereotaxic injection of GRP78WT
adenovirus into the VMH induced feeding-independent weight
loss in OZR, but not in LZR (Figures 5C and 5D), and ameliorated
hypothalamic ER stress (Figure 5E) without changes in hypotha-
lamic ceramide levels (Figures 5F and 5G).
GRP78 in the VMH Increased BAT Thermogenesis and
Improved the Metabolic Profile of Obese Zucker Rats
Next, we investigated the effect of GRP78 WT adenovirus on
thermogenesis. Our data showed that reversion of hypothalamic
ER stress with GRP78 WT induced a marked increase in UCP1
protein levels in BAT (Figure 6A), as well as increased BAT (Fig-
ure 6C) and core temperature (Figure 6E) in OZR, indicating
increased thermogenesis. These effects were associated with
an improvement in the metabolic phenotype of OZR, as demon-
strated by decreased hepatic steatosis (Figure 6G) associated
with reduced levels of acetyl-coenzyme A carboxylase alpha
(ACCa; data not shown) and iWATweight (Figure 6I) and reduced
circulating cholesterol and TAG levels (Table S2). Of note, no
changes were detected in LZR rats treated with the GRP78 WT
adenovirus (Figures 6A, 6B, 6D, 6F, and 6H).
GRP78 in the VMH Improves Leptin Signaling and Insulin
Resistance in Obese Zucker Rats
Administration of GRP78 WT adenovirus into the VMH did not
affect the protein levels of pSTAT3 (phosphorylated signal
transducer and activator of transcription 3), pPI3K (phosphory-
lated phosphatidylinositide 3-kinase), phosphorylated AKT
(pAKT), and SOCS3 (suppressor of cytokine signaling 3) in the
VMH of LZR rats (Figure 7A). GRP78 WT adenoviruses induced
significantly the concentration of pSTAT3, pPI3K, and pAKT in
the VMH of OZR, whereas SOCS3 levels were reduced
(Figure 7B).370 Cell Reports 9, 366–377, October 9, 2014 ª2014 The AuthorsAdministration of GRP78 WT adeno-
virus into the VMH did not affect glucose
tolerance in either LZR or OZR, although
they reduced insulin circulating levels as
early as 30 min after glucose administra-
tion in OZR (Figures 7C and 7D). On the
other hand, GRP78 WT adenoviruses
tended to increase insulin sensitivity in
LZR (Figure 7E). Notably, this effect was
more pronounced in OZR, where a signif-icant improvement in insulin resistance was found (Figure 7F). In
keeping with these data, GRP78 WT adenovirus increased the
levels of pAKT in the muscle (Figure 7H) and the levels of
pPI3K and pAKT in the liver (Figure 7J) of OZR. No significant
changes were observed in LZR (Figures 7G and 7I). Overall,
this evidence demonstrates that GRP78 WT into the VMH treat-
ment improves insulin sensitivity in OZR.
DISCUSSION
This study identifies a physiological link among ceramides, hy-
pothalamic ER stress, and the modulation of energy balance.
Specifically, we show that ceramide-induced hypothalamic lipo-
toxicity and ER stress elicits decreased sympathetic tone to
BAT, which leads to decreased thermogenesis and feeding-in-
dependent weight gain. In addition, we show that genetic mod-
ulation of the ceramide-induced ER stress pathway in a specific
hypothalamic nucleus, the VMH, modulates energy balance by
influencing BAT thermogenesis in a sympathetic nervous system
(SNS)-mediatedmanner and insulin sensitivity, as well as by pro-
moting an overall improvement of the metabolic phenotype of
leptin and insulin resistant obese Zucker rats.
Ceramides comprise a family of simple sphingolipids gener-
ated from fatty acid and sphingosine (Bikman and Summers,
2011; Chavez and Summers, 2012). Although ceramides are pre-
sent at low levels within biological membranes, they make
important contributions to cell membrane structure. In addition,
ceramides exert diverse regulatory effects on cell-signaling
pathways that mediate growth, proliferation, motility, adhesion,
differentiation, senescence, and apoptosis (Holland and Sum-
mers, 2008; Hannun and Obeid, 2008; Cowart, 2009). Increased
ceramide production can lead to ER stress, a mechanism under-
lying insulin resistance and liver diseases (Kahn et al., 2006;
Holland and Summers, 2008; Bikman and Summers, 2011;
Chavez and Summers, 2012). In keeping with this, systemic
Figure 4. Effect of GRP78 Inhibition in the
VMH on Energy Balance
Representative western blot autoradiographic im-
ages (A, left; spliced bands loaded in the same gel)
and hypothalamic protein levels of UPR (A, right),
body weight change (B), daily food intake (C), and
representative western blot autoradiographic im-
ages (D, left; spliced bands loaded in the same gel)
and protein levels of BAT UCP1 (D, right) of rats
treated with GFP or GRP78 DN adenoviruses into
the VMH. Error bars represent SEM; n = 7–9 ani-
mals per experimental group. *p < 0.05, ** p < 0.01,
and ***p < 0.001 versus Ad GFP. See Figure S2 for
analysis of GRP78 DN adenoviruses in the arcuate
nucleus of the hypothalamus.pharmacological inhibition or global genetic ablation of de novo
synthesis of ceramides improves insulin sensitivity and glucose
homeostasis (Summers et al., 1998; Yang et al., 2009) and
protects against glucocorticoid-, saturated fat-, and obesity-
induced insulin resistance (Holland et al., 2007). Current evi-
dence indicates that brain ceramide levels are increased during
high-fat diet-induced obesity (Borg et al., 2012) and in streptozo-
tocin-induced diabetic rats (Car et al., 2012). Also, hypothalamic
ceramide levels regulated by carnitine palmitoyltransferase 1c
(CPT1c, a specific isoform located in the ER), mediate the orexi-
genic effect of ghrelin (Ramı´rez et al., 2013). Finally, current evi-
dence has related hippocampal ceramides with impaired energy
balance and weight gain (Picard et al., 2014). However, despite
of this evidence, no data have linked hypothalamic ceramide-
induced lipotoxicity with ER stress and energy homeostasis.
Therefore, we hypothesized that positive energy balance in
obesity might bemediated by specific alterations in hypothalam-
ic ceramide levels and ER stress.Cell Reports 9, 366–37Our data demonstrate that central
administration of C6 ceramide (which
acts as a long-chain ceramide precursor)
increases the C16 ceramide concentra-
tion in the ventromedial hypothalamus.
Of note, this effect was associated with
feeding-independent weight gain, hypo-
thalamic inflammation (leading to lipotox-
icity), and increased concentration of
UPR proteins (a functional indicator of
elevated ER stress), alongside with a
decrease in SNS firing and thermogenic
capacity of BAT. To determine the physi-
ological relevance of these observations,
we investigated whether selective modu-
lation of hypothalamic UPR (and then ER
stress) was sufficient to overrule central
ceramide’s effects in vivo. For this pur-
pose, we focused on the chaperone
GRP78 (also called BiP). GRP78 is the
most abundant ER-resident chaperone
that can prevent accumulation of
unfolded/misfolded proteins within the
ER (Schro¨der and Kaufman, 2005; Marci-niak and Ron, 2006; Ron andWalter, 2007; Martı´nez deMorentin
and Lo´pez, 2010; Fu et al., 2012; Cnop et al., 2012). Our data
showed that chronic intracerebroventricular (ICV) ceramide
administration increased GRP78 protein concentration in the
MBH, as and adaptive response to ameliorate ER stress. To
test this possibility, we treated rats with adenoviral particles
overexpressing GRP78 specifically within the VMH, which is
known to control BAT thermogenesis through the SNS (Cannon
and Nedergaard, 2004; Lo´pez et al., 2010; Martı´nez de Morentin
et al., 2012, 2014; Whittle et al., 2012; Beiroa et al., 2014). We
show that GRP78 overexpression in the VMH reduces ER stress
and reverses the anabolic effects of central ceramide adminis-
tration by promoting weight loss (independently of food intake),
increasing UCP1 protein content in BAT, and thermogenesis.
Conversely, inactivation of GRP78 (by adenoviral-driven expres-
sion of DN isoforms) within the VMH promotes ER stress and
increases body weight in a feeding-independent manner, in as-
sociation with decreased UCP1 expression in BAT. Remarkably,7, October 9, 2014 ª2014 The Authors 371
Figure 5. Effect of GRP78 Overexpression in the VMH of Obese Zucker Rats on Energy Balance
(A and B) Ceramide levels in themediobasal hypothalamus (A) and representative western blot autoradiographic images (B, left; spliced bands loaded in the same
gel) and hypothalamic protein levels of UPR (B, right) in LZR and OZR.
(C–G) Body weight change (C and D, left) and daily food intake (C and D, right) from LZR and OZR, respectively; representative western blot autoradiographic
images (E, left; spliced bands loaded in the same gel) and VMH protein levels of UPR from OZR (E, right); and ceramide levels in the mediobasal hypothalamus of
LZR (F) and OZR (G) stereotaxically treated with GFP or GRP78 WT adenoviruses into the VMH.
Error bars represent SEM; n = 7–33 animals per experimental group. *p < 0.05, **p < 0.01, ***p < 0.001 versus LZR or OZR Ad GFP.no effect on body weight or BAT thermogenesis was detected
when GRP78 was targeted (by using either WT or DN adenovi-
ruses) in the neighboring ARC, which has been primarily involved
in the regulation of feeding, rather than energy expenditure (Yeo
and Heisler, 2012; Williams and Elmquist, 2012; Lo´pez et al.,
2013). Overall, these data suggest that ceramides and GRP78
regulate energy balance in anatomical-specific pattern. In keep-
ing with this concept, ceramide-induced insulin resistance is
also improved when GRP78 was overexpressed within the
VMH that is also recognized as key site modulating glucose ho-
meostasis (McCrimmon et al., 2006, 2008). Although, classically,
the VMH is considered to be a regulator of feeding control (‘‘the
satiety center’’), our data reinforce recent proofs revealing a
more complex physiological role. These data support the idea
that the VMH is a fundamental brain area in the regulation of ther-
mogenesis and energy balance, integrating peripheral signaling
(i.e., thyroid hormones, bone morphogenetic protein 8b, estra-372 Cell Reports 9, 366–377, October 9, 2014 ª2014 The Authorsdiol, and glucagon like peptide-1) and metabolite sensing (i.e.,
fatty acids and ceramides) with cellular energy sensors (i.e.,
AMP-activated protein kinase) (McCrimmon et al., 2006, 2008;
Lo´pez et al., 2008, 2010; Whittle et al., 2012; Martı´nez deMoren-
tin et al., 2014; Beiroa et al., 2014) and now with cellular machin-
ery, namely ER stress and UPR.
A typical problem associated with malfunction of the central
mechanism governing energy balance is the development of
resistance to peripheral signals, such as insulin and leptin
(Caro et al., 1996; Howard et al., 2004). Current evidence has
demonstrated that one of the pathological mechanisms of leptin
resistance is hypothalamic ER stress (Zhang et al., 2008; Hosoi
et al., 2008; Ozcan et al., 2009; Won et al., 2009; Ropelle et al.,
2010; Schneeberger et al., 2013). Remarkably, these studies
demonstrate that pharmacological interventions that improve
protein folding (i.e., chemical chaperones) recover leptin and
insulin signaling, normalizing body weight (Zhang et al., 2008;
Figure 6. Effect of GRP78 Overexpression
in the VMH of Obese Zucker Rats on BAT
Thermogenesis and Liver Steatosis
Representative western blot autoradiographic im-
ages (A, left; spliced bands loaded in the same gel)
and protein levels of BAT UCP1 (A, right); repre-
sentative infrared thermal images (B and C, left)
and temperature of the BAT area (B and C, right);
rectal temperature (D and E); representative oil red
O-stained liver sections (F and G, left; scale bar,
50 mm) and their quantification (F and G, right
panel); and weight of iBAT, gWAT, and iWAT pads
from LZR (H) and OZR (I) stereotaxically treated
with GFP or GRP78 WT adenoviruses into the
VMH. Error bars represent SEM; n = 7–9 animals
per experimental group. *p < 0.05 and **p < 0.01
versus LZR or OZR Ad GFP; ##p < 0.01 OZR Ad
GFP versus OZR Ad GRP78 WT.Hosoi et al., 2008; Ozcan et al., 2009; Won et al., 2009; Schnee-
berger et al., 2013). Nevertheless, most of the current evidence
has been related to the ARC (i.e., melanocortin neurons) and
feeding. Here, we focused on the pathophysiological relevance
of ER stress in the VMH using a well-established model of leptin
resistance, the OZR, which presents a defective leptin receptor
signaling (Phillips et al., 1996). We observed increased hypotha-
lamic ceramide levels in Zucker rats, associated with increased
UPR and ER stress in the VMH. Next, we stereotaxically treated
OZR with an adenovirus harboring GRP78 into the VMH. That
paradigm recapitulated the previous data, with GRP78 promot-
ing an amelioration of the hypothalamic ER stress associated
with marked negative energy balance in OZR, leading to
increased BAT thermogenesis, and improved metabolic profile
as indicated by the weight loss and the increased leptin signaling
and insulin sensitivity, as well as reduced liver steatosis andCell Reports 9, 366–377circulating lipid levels. Notably, these ef-
fects were totally independent of feeding
behavior, as food intake remained un-
changed after the adenoviral treatment.
Overall, these data indicate that modula-
tion of ER stress in the VMH ameliorates
obesity in an extreme model of leptin
resistance, which is a condition in human
obesity (Caro et al., 1996; Howard et al.,
2004).
Conventionally, the toxic effects of the
accumulation of lipids, such as ceram-
ides, have been located in peripheral tis-
sues, such as pancreatic b cells, and liver,
heart, and skeletal muscle, where they
have been linked with inflammation and
the pathophysiology of insulin resistance,
type 2 diabetes, liver disease, atheroscle-
rosis, and cardiovascular disease (Unger,
2002; Virtue and Vidal-Puig, 2008; Sy-
monsandAbel, 2013).Of note, lipotoxicity
can also occur in the CNS, as observed in
certain neurodegenerative disorders (i.e.,polyglutamine diseases, Parkinson’s disease, and amyotrophic
lateral sclerosis) (Ilieva et al., 2007). However, one key question
that remained to be addressed relates the status of lipid meta-
bolismandwhether accumulation of specific lipid species occurs
in the hypothalamus, leading to lipotoxicity, which might have
deleterious effects on energy homeostasis. Here, we present ev-
idence demonstrating that ceramides play a key role within the
hypothalamus to modulate energy balance through induction of
lipotoxicity ER stress and modulation of BAT function. Thus,
our data provide an alternative hypothalamic-centered paradigm
showing that amelioration of central ER stress leads to a marked
improvement inweight gain in a geneticmodel of obesity.Overall,
these data identify a network involving central ceramides, hypo-
thalamic lipotoxicity, ER stress, andVMH-regulatedBAT thermo-
genesis as a pathophysiological mechanism promoting obesity
and a promising target for therapeutic intervention., October 9, 2014 ª2014 The Authors 373
(legend on next page)
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EXPERIMENTAL PROCEDURES
Animals
Male Sprague-Dawley rats (200–250 g; Animalario General University of San-
tiago deCompostela (USC), Santiago deCompostela, Spain and Charles River
Laboratories) and obese Zucker rats (OZR; fa/fa; 300–350 g) and their controls,
LZR (fa/; 250–300 g), both provided by Charles River, were used for the ex-
periments. All animals were housed on a 12 hr light (8:00 to 20:00), 12 hr dark
cycle, in a temperature- and humidity-controlled room. The animals were al-
lowed free access to standard laboratory pellets of rat chow and tap water.
In all the experimental settings, animals and their food were weighed daily
at the beginning of the light phase. The experiments were performed in
agreement with the International Law on Animal Experimentation and were
approved by the USC Local Ethical Committee, the Xunta de Galicia (Project
ID 15010/14/006), and the University of Iowa Institutional Animal Care and
Use Committee.
Implantation of Intracerebroventricular Cannulae and Central
Treatments
Chronic ICV cannulae were implanted under ketamine-xylazine anesthesia
(50 mg/kg, intraperitoneal), as described previously, and correct positioning
in the lateral ventricle was confirmed by postmortem histological examination
(Lo´pez et al., 2008, 2010; Whittle et al., 2012; Martı´nez de Morentin et al.,
2014). A catheter tube was connected from the brain infusion cannulae to an
osmotic minipump flow moderator (model 2001; Alzet). The minipump was in-
serted in a subcutaneous pocket on the dorsal surface of the animal, created
using blunt dissection. The incision was closed with surgical sutures. The rats
were then infused with C6 ceramide (N-hexanoyl-D-sphingosine; 1.25 mg/ml
dissolved in saline containing one-third DMSO; Sigma-Aldrich) or vehicle (sa-
line containing one-third DMSO; control rats) for 5 days. The selection of these
doses was based on previous reports (Ramı´rez et al., 2013). The animals were
caged individually and used for experimentation 5–7 days later. During this
postoperative recovery period, the rats became accustomed to the handling
procedure under nonstressful conditions.
Stereotaxic Microinjection of Adenoviral Expression Vectors
Rats were placed in a stereotaxic frame (David Kopf Instruments) under keta-
mine-xylazine anesthesia. The VMH and ARC were targeted bilaterally using a
25G needle (Hamilton). The injections were directed to the following stereo-
taxic coordinates: (1) for the VMH, 2.4/3.2 mm posterior to the bregma (two
injections were performed in each VMH), ±0.6 mm lateral to midline and
10.1 mm ventral; and (2) for the ARC, 2.8 posterior to bregma, ±0.3 mm lateral
to midline and 10.2 mm ventral, as previously reported (Lo´pez et al., 2008;
Lo´pez et al., 2010;Whittle et al., 2012; Martı´nez deMorentin et al., 2014; Beiroa
et al., 2014). Adenoviral vectors (Viraquest) containing GFP (used as control),
GRP78 WT (at 1012 particles/ml), GRP78 DN (dominant-negative, at 108 parti-
cles/ml) (Hendershot et al., 1995) were delivered at a rate of 200 nl/min for
5 min (1 ml/injection site) as previously reported (Lo´pez et al., 2008, 2010;
Whittle et al., 2012; Martı´nez de Morentin et al., 2014; Beiroa et al., 2014).
Animals were treated for 6–9 days.
Glucose and Insulin Tolerance Tests
Seven days after stereotaxic surgery, blood glucose levels were measured at
0, 15, 30, and 60min after glucose or insulin administration with an glucometer
(Accucheck, Roche) after an intraperitoneal injection of 0.75 U/kg insulin
(Actrapid, Novonordisk) for insulin tolerance test (ITT) or 2 mg/g D-glucoseFigure 7. Effect of GRP78 Overexpression in the VMH of Obese Zu
Sensitivity
Representative western blot autoradiographic images (A and B, left; spliced ban
pathway in the VMH (A and B, right) from LZR and OZR; GTT (C and D, left) and ser
ITT (E and F, left) and area under the curve (AUC) from ITT (E and F, right); and r
loaded in the same gel) and protein levels of insulin signaling pathway in skeletal m
GRP78WT adenoviruses into the VMH. Error bars represent SEM; n = 6 (pAKT and
and ***p < 0.001 versus LZR Ad GFP or OZR Ad GFP.(Sigma-Aldrich) administered orally via gavage for glucose tolerance test
(GTT) (Beiroa et al., 2013). In this case, the animals were fasted overnight.
To assay insulin sensitivity, insulin (100 U/ml; Actrapid, Novonordisk) was in-
jected in the portal vein. Thirty seconds after the insulin injection, the liver
was removed, and 90 s later the gastrocnemius muscle was extracted. All
samples were immediately homogenized on ice.
Ceramide Quantification
Ceramides were extracted and analyzed via an liquid chromatography-electro-
spray ionization/multistage mass spectrometry system (API 3000 PE Sciex;
Spectralab Scientific) in positive ionization as formerly described (Ramı´rez
et al., 2013). Concentrations weremeasured bymultiple reaction monitoring ex-
perimentsusingN-heptadecanoyl-D-erythro-sphingosine (C17- ceramide) asan
internal standard (50 ng/ml). The method was linear over the range from 2 to
600 ng/ml using as patrons N-palmitoyl-D-erythro-sphingosine (C16 ceramide)
and N-stearoyl-D-erythro-sphingosine (C18 ceramide; Avanti Polar Lipids).
Sample Processing and Analytical Methods
Sample processing, serum analyses, temperature measurements, sympa-
thetic nerve activity (SNA) recording, real-time quantitative PCR, western
blotting, and immunohistochemistry were performed as described previously
(Lo´pez et al., 2008, 2010; Whittle et al., 2012; Martı´nez deMorentin et al., 2012,
2014; Seoane-Collazo et al., 2014; Beiroa et al., 2014) (see the Supplemental
Experimental Procedures for detailed protocols).
Statistical Analysis
Data are expressed as mean ± SEM. mRNA, and protein data were expressed
in relation (%) to control (vehicle or GFP-treated) rats. SNAwas expressed as a
percent change from baseline. Statistical significance was determined by
t-Student when two groupswere compared or ANOVA and post hoc two-tailed
Bonferroni test when more than two groups were compared. p < 0.05 was
considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.08.057.
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